Pure tirzepatide solutions without B12 appear clear or slightly opalescent
Dosing information Usual Adult Dose for Pernicious Anemia: Initial dose: 100 mcg intramuscularly or deep subcutaneous once a day for 6 to 7 days If clinical improvement and reticulocyte response is seen from the above dosing: 100 mcg every other day for 7 doses, then: 100 mcg every 3 to 4 days for 2 to 3 weeks, then: Maintenance dose: 100 to 1000 mcg monthly Duration of therapy: Life Comments: Administer concomitant folic acid if needed
GHK-Cu's non-hormonal mechanism makes it suitable for women
Preservative-free formulation to minimise risk of irritation: Formulated without preservatives, this injection reduces the likelihood of sensitivity or local reactions
Both have been studied in overlapping contexts (fibroblast proliferation in cited models, tendon repair, muscle injury), but through different enough mechanisms that combination research is scientifically justified
The safety of the treatment for the baby is not fully known